Goldman Sachs analyst David Roman initiated coverage of Solventum with a Sell rating and $54 price target. The analyst sees lower end market growth for the company and says Solventum’s relative positioning is likely to drive sales growth in the 0%-2% range for the next several years. The firm does not project the company to reach a sustainable sales and earnings profile until 2028 with potential downward earnings revisions.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLV:
- Solventum downgraded to Hold from Buy at Spin-Off Research
- Warner Bros. upgraded, Cerence downgraded: Wall Street’s top analyst calls
- Solventum initiated with a Neutral at BofA
- Solventum backs FY24 adjusted EPS view $6.10-$6.40, consensus $6.27
- Solventum reports Q1 adjusted EPS $2.08, consensus $1.74